Rps Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-07-2024
- Paid Up Capital ₹ 1.00 M
as on 02-07-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.84 Cr
as on 02-07-2024
- Revenue 7.01%
(FY 2023)
- Profit -54.77%
(FY 2023)
- Ebitda -75.20%
(FY 2023)
- Net Worth -5.36%
(FY 2023)
- Total Assets -7.65%
(FY 2023)
About Rps Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.84 Cr.
Shashikant Gulumkar, Prakash Khalate, and Ramesh Patil serve as directors at the Company.
- CIN/LLPIN
U01200PN2011PTC138512
- Company No.
138512
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Social Media
- Apps
What products or services does Rps Biotech Private Limited offer?
Rps Biotech Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Health Supplement, Herbal Supplements, Ayurvedic,Herbal Products & Medicine, Ayurvedic Immunity Booster, Ayurvedic Medicine, Salon, Spa Kits & Equipments, Shaving Accessories.
Who are the key members and board of directors at Rps Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashikant Gulumkar  | Director | 13-Feb-2011 | Current |
| Prakash Khalate | Director | 13-Feb-2011 | Current |
| Ramesh Patil | Director | 13-Feb-2011 | Current |
Financial Performance of Rps Biotech.
Rps Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.01% increase. The company also saw a substantial fall in profitability, with a 54.77% decrease in profit. The company's net worth dipped by a decrease of 5.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rps Biotech?
In 2023, Rps Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dhanwantari Distributors Private LimitedActive 16 years 1 monthShashikant Gulumkar, Prakash Khalate and 1 more are mutual person
Dhanwantari Global Krushak Producer Company LimitedActive 3 years 11 monthsShashikant Gulumkar, Prakash Khalate and 1 more are mutual person
- Siachen Berries And Fruits Private LimitedActive 3 years 4 months
Prakash Khalate is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Mar 2019 | ₹1.84 Cr | Open |
How Many Employees Work at Rps Biotech?
Rps Biotech has a workforce of 22 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rps Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rps Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
